According to a recent study issued on Thursday, the number of females living with advanced breast cancer are significantly increasing in the US which leads to an improved survival amid all aged.
The study discovered that from 1992 to 1994 and from 2005 to 2012, the five-year survival rate among females under 50 years old who were originally diagnosed with advanced illness multiplied from 18% to 36%.
Who wrote the study?
The average survival period for that group jumped from 22.3 months to around 39 months. For women aging between 50 and 64, the survival time increased from about 19 months to about 30 months.
Angela Mariotto, Chief of the Data Analytics Branch (DAB) of the Surveillance Research Program (SRP) in the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI), is the lead researcher and author of this study.
Others researchers were part of the study such as Fred Hutchinson Cancer Research Center in Seattle as well as the Metastatic Breast Cancer Alliance.
The study’s results
Mariotto believes the results are “favorable” because they were partially because of longer survival periods causing improved treatments.
For example, Herceptin, a drug that was approved in the 1990s, has proved to extend women lives, specifically those who have aggressive breast cancers.
After some calculations, researchers affirmed that more than 154,000 women are now living with cancer which has spread and grew beyond the breast, the most advanced level of breast cancer.
For example, Metastatic breast cancer was believed to be incurable and a death sentence for patients. However, researchers said that new treatments aiming at the triggers of the illness as well as better care indicate women “can and often do live for years with reasonable quality of life, albeit undergoing constant treatment to keep their disease under control.”